Literature DB >> 17056866

Calcified occlusion of the right coronary artery in Kawasaki disease: evidence of myocardial ischaemia using cardiac technetium-99m-tetrofosmin perfusion single-photon emission computed tomography.

J Beamish1, M J O'Connell, A El Khuffash, D F Duff, C J McMahon.   

Abstract

We report the case of a 14-year-old boy who developed Kawasaki disease at 5 months of age. The patient developed severe aneurysmal disease of both the left and right coronary arteries. He eventually developed total calcified occlusion of the right coronary artery despite long-term treatment with aspirin. Catheterisation showed no antegrade flow into the right coronary artery, with retrograde flow from the left coronary system into the right coronary. At the most recent follow-up he was asymptomatic, with normal exercise tolerance and a negative exercise stress test. Single-photon emission computed tomography (SPECT) myocardial perfusion imaging was carried out during stress and at rest using intravenous persantine (dipyridamole) and technetium-99m tetrofosmin. During stress, there were prominent left ventricular apical and anteroseptal defects, which normalised at rest. SPECT during stress and at rest may detect subclinical ischaemia and influence further management options in such patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17056866      PMCID: PMC2082938          DOI: 10.1136/adc.2006.099630

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  10 in total

1.  Myocardial ischemia in Kawasaki disease: evaluation with dipyridamole stress technetium 99m tetrofosmin scintigraphy.

Authors:  Tsuyoshi Fukuda; Masatoshi Ishibashi; Tatsuo Yokoyama; Masaki Otaki; Tohru Shinohara; Yoshihide Nakamura; Toshiharu Miyake; Takashi Kudoh; Hidetaka Oku
Journal:  J Nucl Cardiol       Date:  2002 Nov-Dec       Impact factor: 5.952

2.  Detection of myocardial contractile reserve by low-dose dobutamine quantitative gated single-photon emission computed tomography in patients with Kawasaki disease and severe coronary artery lesions.

Authors:  Kensuke Karasawa; Michio Miyashita; Kazuo Taniguchi; Hiroshi Kanamaru; Mamoru Ayusawa; Nobutaka Noto; Naokata Sumitomo; Tomoo Okada; Kensuke Harada
Journal:  Am J Cardiol       Date:  2003-10-01       Impact factor: 2.778

3.  Prognostic value of dipyridamole-thallium myocardial scintigraphy in patients with Kawasaki disease.

Authors:  M Miyagawa; T Mochizuki; K Murase; S Tanada; J Ikezoe; M Sekiya; K Hamamoto; S Matsumoto; M Niino
Journal:  Circulation       Date:  1998-09-08       Impact factor: 29.690

4.  Coronary artery revascularization in an adult with coronary aneurysms probably secondary to childhood Kawasaki disease.

Authors:  T Sato; T Isomura; N Hayashida; S Aoyagi
Journal:  Eur J Cardiothorac Surg       Date:  1997-08       Impact factor: 4.191

5.  Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  Jane W Newburger; Masato Takahashi; Michael A Gerber; Michael H Gewitz; Lloyd Y Tani; Jane C Burns; Stanford T Shulman; Ann F Bolger; Patricia Ferrieri; Robert S Baltimore; Walter R Wilson; Larry M Baddour; Matthew E Levison; Thomas J Pallasch; Donald A Falace; Kathryn A Taubert
Journal:  Pediatrics       Date:  2004-12       Impact factor: 7.124

6.  Long-term outcome of myocardial revascularization in patients with Kawasaki coronary artery disease. A multicenter cooperative study.

Authors:  S Kitamura; Y Kameda; T Seki; K Kawachi; M Endo; Y Takeuchi; T Kawasaki; Y Kawashima
Journal:  J Thorac Cardiovasc Surg       Date:  1994-03       Impact factor: 5.209

7.  Occlusion of the right coronary artery as sequelae of Kawasaki disease: the clinical features of 9 cases.

Authors:  N Takahashi; J Fukushige; T Hijii; H Igarashi; A Ooshima; K Ueda
Journal:  Cardiology       Date:  1995       Impact factor: 1.869

8.  Scintigraphic monitoring of coronary artery occlusion due to Kawasaki disease.

Authors:  C Kondo; T Nakanishi; T Sonobe; K Tatara; K Momma; K Kusakabe
Journal:  Am J Cardiol       Date:  1993-03-15       Impact factor: 2.778

9.  Poor agreement between dipyridamole-stress technetium-99m-tetrofosmin myocardial perfusion single photon emission computed tomography and two-dimensional echocardiography in Kawasaki disease.

Authors:  Y C Fu; F Y Liu; S C Tsai; B Hwang; C S Chi
Journal:  Int J Cardiol       Date:  2003-07       Impact factor: 4.164

10.  Discordance between dipyridamole stress technetium-99m tetrofosmin single photon emission computed tomography and coronary angiography in patients with Kawasaki disease.

Authors:  Yun-Ching Fu; Yu-Chien Shiau; Shih-Chuan Tsai; Albert Kao; Betau Hwang; Ching-Shiang Chi
Journal:  Int J Cardiovasc Imaging       Date:  2002-10       Impact factor: 2.357

  10 in total
  1 in total

Review 1.  Imaging studies in the diagnosis and management of vasculitis.

Authors:  Luis M Amezcua-Guerra; Carlos Pineda
Journal:  Curr Rheumatol Rep       Date:  2007-08       Impact factor: 4.592

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.